Log In
Print
BCIQ
Print
Print this Print this
 

neostigmine methylsulfate (Bloxiverz)

  Manage Alerts
Collapse Summary General Information
Company Flamel Technologies S.A.
DescriptionCholinesterase inhibitor
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentMarketed
Standard Indication Neurology (unspecified)
Indication DetailsReverse the effects of non-depolarizing neuromuscular blocking agents after surgery
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today